Sandu Pharmaceuticals Board Meeting Scheduled Following Demise of Managing Director

Sandu Pharmaceuticals Board Meeting Scheduled Following Demise of Managing Director​

Sandu Pharmaceuticals Ltd has scheduled a Board meeting to address significant changes in its senior management following the demise of Shri Umesh B. Sandu, the company's erstwhile Managing Director.

The Board of Directors is set to meet on Saturday, July 11, 2026, at the Company's Corporate Office located in Mumbai. The primary purpose of the meeting is to place on record the death of Shri Umesh B. Sandu, who passed away on June 19, 2026. The Board will also formally recognize and appreciate his invaluable contribution to Sandu Pharmaceuticals Ltd.

Key items for discussion at the board meeting include the appointment of a new Managing Director of the Company. This appointment is subject to the approval of shareholders and any required statutory or regulatory approvals. Additionally, the agenda includes considering and approving the reconstitution of the Board's committees and the appointment of an Additional Director in the capacity of an Independent Director (Non-Executive). Both these appointments are contingent upon shareholder approval and relevant statutory requirements.

In matters concerning compliance for its employees, Sandu Pharmaceuticals has advised that the trading window for dealing in the Securities of the Company has been closed. This restriction applies to Directors and designated employees, running from the opening of Trading hours on Wednesday, July 1st, up until 48 hours after the announcement of financial results for the quarter ending June 30, 2026.

Stock Price Movement​

As of 10:46, Sandu Pharmaceuticals Ltd is ticking up after rising by 0.02%, trading at ₹41.60. Shares have traded within a tight intraday band, moving between the low of ₹41.50 and the high of ₹41.60.